Security assessments indicated that gastrointestinal adverse gatherings, primarily nausea and diarrhea, had been dose-dependent but usually gentle and transient. These conclusions recognized the therapeutic window and educated dose choice for subsequent Stage 3 trials.“Noom produced the procedure so basic and now I feel whole, free of charge from